Switch theme
Sign up to access all valuation multiples
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
2001
80
LTM Revenue $26.8M
Last FY EBITDA -$15.7M
$8.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Lifeward has a last 12-month revenue (LTM) of $26.8M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Lifeward achieved revenue of $25.7M and an EBITDA of -$15.7M.
Lifeward expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Lifeward valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $26.8M | XXX | $25.7M | XXX | XXX | XXX |
| Gross Profit | $10.3M | XXX | $8.2M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 32% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$15.7M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -61% | XXX | XXX | XXX |
| EBIT | -$14.0M | XXX | -$19.6M | XXX | XXX | XXX |
| EBIT Margin | -52% | XXX | -76% | XXX | XXX | XXX |
| Net Profit | -$21.4M | XXX | -$28.9M | XXX | XXX | XXX |
| Net Margin | -80% | XXX | -113% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Lifeward's stock price is $1.
Lifeward has current market cap of $13.5M, and EV of $8.4M.
See Lifeward trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.4M | $13.5M | XXX | XXX | XXX | XXX | $-2.35 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Lifeward has market cap of $13.5M and EV of $8.4M.
Lifeward's trades at 0.3x EV/Revenue multiple, and -0.5x EV/EBITDA.
Equity research analysts estimate Lifeward's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lifeward has a P/E ratio of -0.6x.
See valuation multiples for Lifeward and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13.5M | XXX | $13.5M | XXX | XXX | XXX |
| EV (current) | $8.4M | XXX | $8.4M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -0.5x | XXX | XXX | XXX |
| EV/EBIT | -0.6x | XXX | -0.4x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.6x | XXX | -0.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialLifeward's last 12 month revenue growth is 36%
Lifeward's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.
Lifeward's rule of 40 is -121% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lifeward's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Lifeward and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 36% | XXX | 37% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -61% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -121% | XXX | -25% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 70% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 108% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lifeward acquired XXX companies to date.
Last acquisition by Lifeward was XXXXXXXX, XXXXX XXXXX XXXXXX . Lifeward acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Lifeward founded? | Lifeward was founded in 2001. |
| Where is Lifeward headquartered? | Lifeward is headquartered in United States of America. |
| How many employees does Lifeward have? | As of today, Lifeward has 80 employees. |
| Who is the CEO of Lifeward? | Lifeward's CEO is Mr. Lawrence J. Jasinski. |
| Is Lifeward publicy listed? | Yes, Lifeward is a public company listed on NAS. |
| What is the stock symbol of Lifeward? | Lifeward trades under LFWD ticker. |
| When did Lifeward go public? | Lifeward went public in 2014. |
| Who are competitors of Lifeward? | Similar companies to Lifeward include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Lifeward? | Lifeward's current market cap is $13.5M |
| What is the current revenue of Lifeward? | Lifeward's last 12 months revenue is $26.8M. |
| What is the current revenue growth of Lifeward? | Lifeward revenue growth (NTM/LTM) is 36%. |
| What is the current EV/Revenue multiple of Lifeward? | Current revenue multiple of Lifeward is 0.3x. |
| Is Lifeward profitable? | Yes, Lifeward is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
